Daston GP, Rogers JM, Versteeg DJ, Sabourin TD, Baines D, Marsh SS (1991) Interspecies comparisons of A/D ratios are not constant across species. Fund Appl Toxicol17:696–722.
2.
Gaylor DW. (1992) Incidence of developmental defects at the no observed adverse effect level (NOAEL). Reg Toxicol Pharmacol15:151–60.
3.
Hoar RM. (1995) Developmental toxicity: exptrapolation across species. J Am Coll Toxicol14:11–20.
4.
Johnson EM. (1987) A tier system for developmental toxicity evaluations based on considerations of exposure and effect relationships. Teratology35:405–27.
5.
Johnson EM, Newman LM, Gabel BEG, Boerner TE, Dansky LA. (1988) An analysis of the Hydra assay's applicability and reliability as a developmental toxicity prescreen. J Am Coll Toxicol7:111–26.
6.
Rogers JM. (1987) Comparison of maternal and fetal toxic dose responses in mammals. Teratogen Carcinogen Mutagen7:297–306.
7.
Schardein JL. (1987) Approaches to defining the relationship of maternal and developmental toxicity. Teratogen Carcinogen Mutagen7:255–71.
8.
Setzer RW, Rogers JM. (1991) Assessing developmental hazard: the reliability of the A/D ratio. Teratology44:653–65.
